3-fluoromethamphetamine (also known as 3-fma) is a novel synthetic ring-substituted fluorinated amphetamine compound that produces entactogenic and stimulant effects when administered. following the introduction of 3-fea, 3-fma subsequently entered the designer drug market as a compound structurally related to a series of fluorinated substituted amphetamines that originally included compounds such as 2-fma, 3-fa, 4-fma, 4-fa.
like its parent compound 3-fa, the pharmacological, toxicological, and subjective effects of 3-fma in humans have yet to be mapped out in detail. early reports have so far characterized 3-fma as a moderately potent serotonin-dominant triple monoamine releaser (or reuptake inhibitor) that produces a relatively short-lived balance of entactogenic and stimulant effects. based on related compounds, it is not unreasonable to speculate that this compound possesses neurotoxic, cardiotoxic and other potential to-be-discovered toxic properties, which is why extreme caution is advised.
3-fma has an extremely short history of recreational use and has yet to be documented being sold on the streets. it has recently been made available for sale on the gray market as a research chemical through online vendors. the appearance of it as well as 3-fea on the research chemicals market coincides with the increased efforts to control the popular entactogenic stimulant 4-fa.
due to its potent psychostimulant effect, likely habit-forming properties as well as unknown toxicity profile, it is strongly recommended that one use proper harm reduction practices if choosing to use this substance.
3-fma, or 3-fluoromethamphetamine, is a synthetic molecule of the amphetamine family. molecules of the amphetamine family contain a phenethylamine core featuring a phenyl ring bound to an amino (nh2) group through an methyl chain with an additional methyl substitution at rα (i.e. amphetamines are alpha-methylated phenethylamines). 3-fma is the 3-position fluorinated analog methamphetamine; however, it is currently speculated to behave more in the manner of shorter-lived entactogenic stimulant. additionally, is is also a positional isomer of 2-fma and 4-fma.
although 3-fma has not been formally studied on the same level as traditional amphetamines, it is currently assumed that like other substituted amphetamines with substitutions at similar positions, it most likely acts primarily as a triple releasing agent of serotonin, dopamine, and norepinephrine.